 HOUSTON, Sept. 20, 2022 GLOBE NEWSWIRE -- Salarius Pharmaceuticals, Inc. NASDAQ: SLRX, a clinical-stage biopharmaceutical company developing medicines for patients fighting cancer and in need of new treatment options, today announced that management will present at the 2022 Ladenburg Thalmann Healthcare Conference being held on September 29th in New York City at the Sofitel Hotel. David Arthur, chief executive officer, will deliver a corporate presentation and participate in a fireside chat at 10:30 a.m. Eastern time. In addition to Mr. Arthur, other management team members will be available for one-on-one meetings. Please contact Ladenburg Thalmann to schedule a meeting. 